Evaluating the Pharmacokinetics, Safety, and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents
Clinical trial NCT03332095 · COMPLETED
Trial details
- NCT number
- NCT03332095
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-02
- Primary completion
- 2020-08-19
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.